Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells.

Fan Y, Ge N, Wang X, Sun W, Mao R, Bu W, Creighton CJ, Zheng P, Vasudevan S, An L, Yang J, Zhao YJ, Zhang H, Li XN, Rao PH, Leung E, Lu YJ, Gray JW, Schiff R, Hilsenbeck SG, Osborne CK, Yang J, Zhang H.

J Pathol. 2014 Jan;232(1):75-86. doi: 10.1002/path.4283.


RNAi silencing of the MEKK3 gene promotes TRAIL-induced apoptosis in MCF-7 cells and suppresses the transcriptional activity of NF-κB.

Guo SY, Liu SG, Liu L, Zhou XJ, Gu Y.

Oncol Rep. 2012 Feb;27(2):441-6. doi: 10.3892/or.2011.1509. Epub 2011 Oct 20.


Function of RasGRP3 in the formation and progression of human breast cancer.

Nagy Z, Kovács I, Török M, Tóth D, Vereb G, Buzás K, Juhász I, Blumberg PM, Bíró T, Czifra G.

Mol Cancer. 2014 Apr 29;13:96. doi: 10.1186/1476-4598-13-96.


The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.

Zhang N, Wang X, Huo Q, Li X, Wang H, Schneider P, Hu G, Yang Q.

J Biol Chem. 2013 Mar 29;288(13):9396-407. doi: 10.1074/jbc.M112.395913. Epub 2013 Feb 13.


Overexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB.

Samanta AK, Huang HJ, Bast RC Jr, Liao WS.

J Biol Chem. 2004 Feb 27;279(9):7576-83. Epub 2003 Dec 8.


Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.

Shiang CY, Qi Y, Wang B, Lazar V, Wang J, Fraser Symmans W, Hortobagyi GN, Andre F, Pusztai L.

Breast Cancer Res Treat. 2010 Oct;123(3):747-55. doi: 10.1007/s10549-009-0677-6. Epub 2009 Dec 19.


Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells.

Wang Q, Maloof P, Wang H, Fenig E, Stein D, Nichols G, Denny TN, Yahalom J, Wieder R.

Exp Cell Res. 1998 Jan 10;238(1):177-87.


Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray.

Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Elliott S, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME.

Surgery. 2002 Aug;132(2):293-301.


The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer.

Zhou Z, Liu R, Chen C.

Int J Cancer. 2012 Apr 1;130(7):1504-10. doi: 10.1002/ijc.26122. Epub 2011 May 30.


Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.

Yoshida T, Zhang Y, Rivera Rosado LA, Zhang B.

Mol Cancer Res. 2009 Nov;7(11):1835-44. doi: 10.1158/1541-7786.MCR-09-0244. Epub 2009 Oct 20.


Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.

Chen J, Gomes AR, Monteiro LJ, Wong SY, Wu LH, Ng TT, Karadedou CT, Millour J, Ip YC, Cheung YN, Sunters A, Chan KY, Lam EW, Khoo US.

PLoS One. 2010 Aug 20;5(8):e12293. doi: 10.1371/journal.pone.0012293.


EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.

Yao W, Feng D, Bian W, Yang L, Li Y, Yang Z, Xiong Y, Zheng J, Zhai R, He J.

Amino Acids. 2012 Nov;43(5):2027-35. doi: 10.1007/s00726-012-1277-z. Epub 2012 Apr 4.


Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression.

Lin T, Ding Z, Li N, Xu J, Luo G, Liu J, Shen J.

Eur J Cancer. 2011 Aug;47(12):1890-907. doi: 10.1016/j.ejca.2011.04.004. Epub 2011 May 10.


Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.

Alexopoulou AN, Leao M, Caballero OL, Da Silva L, Reid L, Lakhani SR, Simpson AJ, Marshall JF, Neville AM, Jat PS.

Breast Cancer Res. 2010;12(4):R51. doi: 10.1186/bcr2610. Epub 2010 Jul 19.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk